Qiagen cuts outlook on weaker COVID-19 testing trends, shares fall

Go back to Qiagen cuts outlook on weaker COVID-19 testing trends, shares fall

Qiagen NV (QGEN) PT Lowered to $50 at Stifel

July 14, 2021 7:19 AM EDT

Stifel analyst Daniel Arias lowered the price target on Qiagen NV (NYSE: QGEN) to $50.00 (from $55.00) while maintaining a Hold rating.

The analyst commented, "QGEN held a call to discuss the preliminary 2Q results and the outlook for the remainder of the year.... More